ReviewNeuropsychiatric disease and treatment2018

New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab.

Jessica Frau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.